A detailed history of Bank Of America Corp transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 79,598 shares of STTK stock, worth $91,537. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,598
Previous 50,986 56.12%
Holding current value
$91,537
Previous $196,000 41.33%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.0 - $4.85 $85,836 - $138,768
28,612 Added 56.12%
79,598 $277,000
Q2 2024

Aug 14, 2024

SELL
$3.56 - $11.18 $8,234 - $25,859
-2,313 Reduced 4.34%
50,986 $196,000
Q1 2024

May 15, 2024

BUY
$7.37 - $10.09 $46,099 - $63,112
6,255 Added 13.3%
53,299 $476,000
Q4 2023

Feb 14, 2024

BUY
$1.37 - $7.24 $260 - $1,375
190 Added 0.41%
47,044 $335,000
Q2 2023

Aug 14, 2023

SELL
$2.52 - $3.66 $2,315 - $3,363
-919 Reduced 1.92%
46,854 $146,000
Q1 2023

May 12, 2023

BUY
$2.5 - $4.72 $22,637 - $42,739
9,055 Added 23.39%
47,773 $140,000
Q4 2022

Feb 10, 2023

BUY
$1.96 - $3.26 $44,350 - $73,767
22,628 Added 140.63%
38,718 $89,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.52 $41,519 - $88,148
15,969 Added 13197.52%
16,090 $43,000
Q2 2022

Aug 12, 2022

SELL
$2.7 - $4.59 $22,266 - $37,853
-8,247 Reduced 98.55%
121 $0
Q1 2022

May 16, 2022

SELL
$4.22 - $8.89 $54,564 - $114,947
-12,930 Reduced 60.71%
8,368 $35,000
Q4 2021

Feb 08, 2022

BUY
$8.36 - $21.08 $21,368 - $53,880
2,556 Added 13.64%
21,298 $181,000
Q3 2021

Nov 15, 2021

BUY
$17.57 - $28.95 $156,056 - $257,133
8,882 Added 90.08%
18,742 $382,000
Q2 2021

Sep 13, 2021

BUY
$24.14 - $37.68 $238,020 - $371,524
9,860 New
9,860 $286,000

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $48.7M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.